Aiolos Bio
Aiolos Bio is a clinical-stage biotech company developing novel antibody therapeutics for respiratory and inflammatory diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $980M
About
Aiolos Bio is a clinical-stage biotech company developing novel antibody therapeutics for respiratory and inflammatory diseases.
RespiratoryImmunologyAntibodies
Funding History
4Total raised:$980M
Series D$245M
Series C$245M
Series B$245M
Series A$245M